Top broker tips BWX (BWX) share price to leap 42% in 2022

BWX shares have been tipped to outperform in 2022…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The BWX Ltd (ASX: BWX) share price has been a relatively poor performer in 2021.

Since the start of the year, the personal care products company's shares have risen almost 4% to $4.29.

This compares to a gain of 9.6% by the S&P/ASX 200 Index (ASX: XJO) over the same period.

Two women jumping into the air.

Image source: Getty Images

Where next for the BWX share price?

The good news for investors is that one leading broker believes the BWX share price is primed to leap higher in 2022.

According to a recent note out of Bell Potter, its analysts have picked the Sukin manufacturer as one of their top picks for next year.

Bell Potter has put a buy rating and $6.10 price target on the company's shares. Which, based on the current BWX share price, implies potential upside of 42% for investors over the next 12 months.

Why is Bell Potter bullish?

The broker notes that BWX has been busy expanding its distribution footprint in the natural beauty and wellness market. So much so, the broker expects the company's footprint to grow by ~42% year on year in FY 2022.

And while it acknowledges that COVID-19 lockdowns have impacted its retail sales, Bell Potter was pleased to see channels return to normal in November.

All in all, its analysts believe the company is well-placed for the future and see a lot of value in the BWX share price.

Bell Potter commented: "On a look through basis, we believe BWX is well placed to deliver strong Underlying Revenue & EBITDA growth in FY22 (weighted to 2H22) as retail trade normalises and sell-through improves. This should be supported by BWX's recent acquisition of 51% of Go-to Skincare which is tracking +13% vs. PcP in 1Q22, and manufacturing synergies over the medium term as BWX phases in the use of its purpose built facility in CY22. We believe the market has recently priced in expectations for a soft 1H22, which presents a compelling buying opportunity at current levels."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BWX Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »